<p>C57BL/6 mice were infected in the right footpad with WT and <i>lpg2− L. major</i> and after 16 weeks, challenged with virulent <i>L. major</i> in the left footpads. Some mice were treated with anti-IFN-γ or anti-CD8 mAb (1 mg/ml) 24 hr prior to challenge and once weekly for additional 3 weeks. At 3 weeks post-challenge, lesion sizes (<b>A, C</b>) were determined and mice were sacrificed and parasite burdens (<b>B, D</b>) in the challenged footpads were determined. Data presented are representative of 2–3 independent experiments (n = 3–5 mice per group) with similar results.</p
<p>C57BL/6 mice were infected with WT and <i>lpg2− L. major</i> and the kinetics of lesion developme...
<p>(A) Mice were infected subcutaneously with <i>L. major</i> and the footpad lesion was measured we...
<p>Mice deficient in IFN-γ and their WT controls (C57BL/6) were infected in the hind footpads with L...
<p>C57BL/6 mice infected with WT and <i>lpg2</i>− <i>L. major</i> (>16 wks) were challenge with 5 mi...
<p>CD3<sup>+</sup> spleen cells from WT- and <i>lpg2<sup>−</sup> L. major</i>-infected mice were sti...
<p>C57BL/6 mice were infected with low (1×10<sup>3</sup>) or high dose (2×10<sup>6</sup>) <i>L. majo...
<p>(A) N1N2<sup>ΔCD4Cre</sup> and control N1N2<i><sup>lox/lox</sup></i> mice were infected with 3×10...
<p>Mice (n = 8 per group) vaccinated with the LiPABP1 + LiPABP2 + LiPABP3 combined genetic vaccine (...
<p>BALB/c mice were infected with 2 million wild-type (WT) and <i>lpg2− L. major</i> stationary phas...
<p><b>A</b>. Lesion development was assessed by weekly measurement of footpad swelling. <b>B</b>. Pa...
<p>C57BL/6 mice infected with low (1×10<sup>3</sup>) or high (2×10<sup>6</sup>) dose <i>L. major</i>...
<p>Mice were infected s.c. with 3×10<sup>6 </sup><i>L. major</i> promastigotes. (A) The lesion size ...
<p>(A) N1N2<sup>ΔCD4Cre</sup> and control N1N2<i><sup>lox/lox</sup></i> mice were infected s.c. with...
<p>B6, <i>MyD88<sup>−/−</sup></i> and <i>MyD88<sup>−/−</sup>Gt</i> mice were immunized intravenously...
<p><b>A.</b> Induction of protective immunity conferred after infection with the <i>L.inn::vgc strai...
<p>C57BL/6 mice were infected with WT and <i>lpg2− L. major</i> and the kinetics of lesion developme...
<p>(A) Mice were infected subcutaneously with <i>L. major</i> and the footpad lesion was measured we...
<p>Mice deficient in IFN-γ and their WT controls (C57BL/6) were infected in the hind footpads with L...
<p>C57BL/6 mice infected with WT and <i>lpg2</i>− <i>L. major</i> (>16 wks) were challenge with 5 mi...
<p>CD3<sup>+</sup> spleen cells from WT- and <i>lpg2<sup>−</sup> L. major</i>-infected mice were sti...
<p>C57BL/6 mice were infected with low (1×10<sup>3</sup>) or high dose (2×10<sup>6</sup>) <i>L. majo...
<p>(A) N1N2<sup>ΔCD4Cre</sup> and control N1N2<i><sup>lox/lox</sup></i> mice were infected with 3×10...
<p>Mice (n = 8 per group) vaccinated with the LiPABP1 + LiPABP2 + LiPABP3 combined genetic vaccine (...
<p>BALB/c mice were infected with 2 million wild-type (WT) and <i>lpg2− L. major</i> stationary phas...
<p><b>A</b>. Lesion development was assessed by weekly measurement of footpad swelling. <b>B</b>. Pa...
<p>C57BL/6 mice infected with low (1×10<sup>3</sup>) or high (2×10<sup>6</sup>) dose <i>L. major</i>...
<p>Mice were infected s.c. with 3×10<sup>6 </sup><i>L. major</i> promastigotes. (A) The lesion size ...
<p>(A) N1N2<sup>ΔCD4Cre</sup> and control N1N2<i><sup>lox/lox</sup></i> mice were infected s.c. with...
<p>B6, <i>MyD88<sup>−/−</sup></i> and <i>MyD88<sup>−/−</sup>Gt</i> mice were immunized intravenously...
<p><b>A.</b> Induction of protective immunity conferred after infection with the <i>L.inn::vgc strai...
<p>C57BL/6 mice were infected with WT and <i>lpg2− L. major</i> and the kinetics of lesion developme...
<p>(A) Mice were infected subcutaneously with <i>L. major</i> and the footpad lesion was measured we...
<p>Mice deficient in IFN-γ and their WT controls (C57BL/6) were infected in the hind footpads with L...